Condition
Behcet's Syndrome
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
80.0%-7% vs avg
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
80.0%
-6.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
80% success
Data Visualizations
Phase Distribution
4Total
P 1 (1)
P 2 (3)
Trial Status
Completed4
Terminated1
Trial Success Rate
80.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT00550498Phase 1Terminated
Stem Cell Transplantation in Ocular Lesions of Behcet's Disease
NCT00699985CompletedPrimary
Psychological Symptoms in Patients With Behcet's Disease by SCL90-R
NCT00700297Phase 2CompletedPrimary
Colchicine Randomized Double-Blind Controlled Crossover Study in Behcet's Disease
NCT00664599Phase 2CompletedPrimary
Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's Disease
NCT00001865Phase 2CompletedPrimary
HAT in Eye Complications of Behcet's Disease
Showing all 5 trials